Luca Laurenti
65PUBLICATIONS
189CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (65)
Sort by Publication Date:
|Apr 02, 2026
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.Luca Laurenti, Feliciana Guglielmi, Antonio Mosca
|Mar 28, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.Stefano Molica, Potito Rosario Scalzulli, Lydia Scarfò
|Mar 02, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.Jeff P Sharman, Luca Laurenti, Emmanuelle Ferrant
|Feb 12, 2026
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study.Francesco Autore, Alessandra Tedeschi, Giulia Benevolo
|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna
|Jul 11, 2025
Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia.Alice Ramassone, Sara Pagotto, Mirco Di Marco
Pageof 11
Frequent Collaborators
17 joint publications
Francesco Autore
16 joint publications
Alberto Fresa
16 joint publications
Andrea Visentin
12 joint publications
Livio Trentin
12 joint publications
Francesca Romana Mauro
12 joint publications
Massimo Gentile
12 joint publications
Annamaria Frustaci
11 joint publications
Candida Vitale
10 joint publications
Riccardo Moia
10 joint publications
Gianluigi Reda
